Clinical Trials Directory

Trials / Completed

CompletedNCT01037660

Effects of Lipemia and Metformin on Endothelial Function

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
139 (actual)
Sponsor
Boston University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Eating a diet high in fat contributes to the development of atherosclerosis (hardening of the arteries). Acute fat consumption increases levels of fat in the blood and temporarily reduces the ability of blood vessel to dilate (open up to carry additional blood). A similar response is observed during infusion of Intra-Lipid (a fat emulsion used for intravenous nutrition). The present study is designed to help us understand the effects of a fat load on blood vessel function. We will measure arterial dilation using non-invasive techniques before and at the end of a 5-hour infusion of Intra-Lipid in healthy subjects. Subjects will then take the approved drug metformin for two weeks and return for repeat studies of endothelial function with Intra-Lipid infusion. We expect that metformin will help preserve the normal function of blood vessels during a fat load. This study will help us understand how fat affects blood vessels and therefore will advance our knowledge of the development of atherosclerosis and potentially lead to improved methods to prevent and treat heart disease.

Conditions

Interventions

TypeNameDescription
DRUGMetforminMetformin 1 gram per day

Timeline

Start date
2005-09-01
Primary completion
2015-12-01
Completion
2016-12-01
First posted
2009-12-23
Last updated
2017-03-10

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT01037660. Inclusion in this directory is not an endorsement.